← All stocks

Axsome Therapeutics, Inc.

AXSM Scheduled selling only

CIK 0001579428 #896 in the set updated 17 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$140.91M

$8.49M on a plan · $132.41M straight out of an exercise

Sold at will

$0.00

0 of 37 sales

Net

−$140.91M

$0.00 against sales at will

By person

9 insiders · 40 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

TABUTEAU HERRIOT

Chief Executive Officer

—

$103.22M (17) scheduled

−$103.22M

7,229

0.0138%

$1.51M

0.0%

Pizzie Nick

Chief Financial Officer

—

$10.18M (2) scheduled

−$10.18M

42,867

0.0818%

$8.94M

0.0%

Jacobson Mark L.

Chief Operating Officer

—

$10.06M (5) scheduled

−$10.06M

0.0000%

$0.00

−100.0%

Coleman Mark

Director

—

$8.21M (5) scheduled

−$8.21M

30,389

0.0580%

$6.34M

+108.1%

Saad Mark E

Director

—

$6.21M (2) scheduled

−$6.21M

11,431

0.0218%

$2.39M

+14.3%

Maizel Ari

Chief Commercial Officer

—

$2.75M (2) scheduled

−$2.75M

0.0000%

$0.00

—

Mahony Susan

Director

—

$145.02K (2) scheduled

−$145.02K

829

0.0016%

$172.97K

—

JEFFS ROGER

Director

—

$141.66K (2) scheduled

−$141.66K

58,367

0.1114%

$12.18M

−65.2%

Murdock Hunter R.

General Counsel

—

0.0000%

$0.00

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 42

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 9

Sales straight out of an exercise 28

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 797,469

History held since 17 Mar 2017